BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31955413)

  • 1. Integration of Omics Data Sources to Inform Mechanistic Modeling of Immune-Oncology Therapies: A Tutorial for Clinical Pharmacologists.
    Lazarou G; Chelliah V; Small BG; Walker M; van der Graaf PH; Kierzek AM
    Clin Pharmacol Ther; 2020 Apr; 107(4):858-870. PubMed ID: 31955413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology.
    Arulraj T; Wang H; Ippolito A; Zhang S; Fertig EJ; Popel AS
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38557676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
    Gkolfinopoulos S; Mountzios G
    Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.
    Socinski MA
    Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm.
    Chelliah V; Lazarou G; Bhatnagar S; Gibbs JP; Nijsen M; Ray A; Stoll B; Thompson RA; Gulati A; Soukharev S; Yamada A; Weddell J; Sayama H; Oishi M; Wittemer-Rump S; Patel C; Niederalt C; Burghaus R; Scheerans C; Lippert J; Kabilan S; Kareva I; Belousova N; Rolfe A; Zutshi A; Chenel M; Venezia F; Fouliard S; Oberwittler H; Scholer-Dahirel A; Lelievre H; Bottino D; Collins SC; Nguyen HQ; Wang H; Yoneyama T; Zhu AZX; van der Graaf PH; Kierzek AM
    Clin Pharmacol Ther; 2021 Mar; 109(3):605-618. PubMed ID: 32686076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for Immunotherapy.
    Bustamante-Alvarez JG; Owen DH
    Thorac Surg Clin; 2020 May; 30(2):207-214. PubMed ID: 32327179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive Review.
    Katzman D; Wu S; Sterman DH
    J Thorac Oncol; 2018 May; 13(5):624-635. PubMed ID: 29391289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer.
    Jafarnejad M; Gong C; Gabrielson E; Bartelink IH; Vicini P; Wang B; Narwal R; Roskos L; Popel AS
    AAPS J; 2019 Jun; 21(5):79. PubMed ID: 31236847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
    Kakimi K; Nakajima J; Wada H
    Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for thoracic oncology gone viral.
    Patel MR
    Immunotherapy; 2018 Apr; 10(5):383-390. PubMed ID: 29473469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
    Santana-Davila R; Chow LQ
    Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
    [No Abstract]   [Full Text] [Related]  

  • 12. A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development.
    Bai JPF; Earp JC; Strauss DG; Zhu H
    CPT Pharmacometrics Syst Pharmacol; 2020 Dec; 9(12):675-677. PubMed ID: 33159491
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunotherapies and targeted therapies in medical oncology].
    Rousseau B; Champiat S; Loirat D; Arrondeau J; Lemoine N; Soria JC
    Bull Cancer; 2014 Jan; 101(1):31-9. PubMed ID: 24333964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy in non-small cell lung cancer patients: back to the future.].
    Roberto M; Botticelli A; Cecere F; Cognetti F; Giusti R; Gelibter A; Lugini A; Nelli F; Nuti M; Santini D; Marchetti P
    Recenti Prog Med; 2019 Dec; 110(12):587-593. PubMed ID: 31909761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene immunotherapy for non-small cell lung cancer.
    Nemunaitis JJ
    Methods Mol Biol; 2009; 542():499-514. PubMed ID: 19565919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy.
    Carbone DP; Gandara DR; Antonia SJ; Zielinski C; Paz-Ares L
    J Thorac Oncol; 2015 Jul; 10(7):974-84. PubMed ID: 26134219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccines for the treatment of non-small cell lung cancer].
    Leduc C; Quoix E
    Rev Mal Respir; 2019 Mar; 36(3):415-425. PubMed ID: 30902445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for non-small-cell lung cancer.
    Thomas A; Jakopovic M
    Expert Opin Biol Ther; 2014 Aug; 14(8):1061-4. PubMed ID: 24878420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-small cell lung cancer: news from immunotherapy].
    Reinmuth N; Heigener DF; Reck M
    Dtsch Med Wochenschr; 2015 Mar; 140(5):329-33. PubMed ID: 25734674
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.